A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines

Biological Procedures Online

Research

Luke B Hesson¹  Deborah Packham¹  Robyn L Ward¹  Pauline Funchain²  Charis Eng³  Emily Pontzer³ 

[1] Adult Cancer Program, Lowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, 2052, Sydney, NSW, Australia;Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, 44195, Cleveland, OH, USA;Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, 44195, Cleveland, OH, USA;Department of Genetics and CASE Comprehensive Cancer Center, 44116, Cleveland, OH, USA;

关键词: DNA methylation;    Epigenetic;    PTEN;    KILLIN;    PTENP1;    Pseudogene;    Cowden syndrome;   

DOI  :  10.1186/1480-9222-14-5

 received in 2012-03-15, accepted in 2012-04-10,  发布年份 2012

来源: Springer

【 摘 要 】

BackgroundPTEN is an important tumour suppressor gene that is mutated in Cowden syndrome as well as various sporadic cancers. CpG island hypermethylation is another route to tumour suppressor gene inactivation, however, the literature regarding PTEN hypermethylation in cancer is controversial. Furthermore, investigation of the methylation status of the PTEN CpG island is challenging due to sequence homology with the PTEN pseudogene, PTENP1. PTEN shares a CpG island promoter with another gene known as KLLN. Here we present a thorough reinvestigation of the methylation status of the PTEN CpG island in DNA from colorectal, breast, ovarian, glioma, lung and haematological cancer cell lines.ResultsUsing a range of bisulphite-based PCR assays we investigated 6 regions across the PTEN CpG island. We found that regions 1-4 were not methylated in cancer cell lines (0/36). By allelic bisulphite sequencing and pyrosequencing methylation was detected in regions 5 and 6 in colorectal, breast and haematological cancer cell lines. However, methylation detected in this region was associated with the PTENP1 promoter and not the PTEN CpG island.ConclusionsWe show that methylation of the PTEN CpG island is a rare event in cancer cell lines and that apparent methylation most likely originates from homologous regions of the PTENP1 pseudogene promoter. Future studies should utilize assays that reliably discriminate between PTEN and PTENP1 to avoid data misinterpretation.

【 授权许可】

Unknown   
© Hesson et al; licensee BioMed Central Ltd. 2012. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.